Hari Hara Agri Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 0.11 M
as on 16-12-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 82.81%
(FY 2019)
- Profit 15.97%
(FY 2019)
- Ebitda 0.24%
(FY 2019)
- Net Worth 287.09%
(FY 2019)
- Total Assets 191.60%
(FY 2019)
About Hari Hara Agri Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Yogish Chandra, Aruna Tulasi, and Kodanda Javvadi serve as directors at the Company.
- CIN/LLPIN
U01100TG2004PTC044352
- Company No.
044352
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2004
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hari Hara Agri Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kodanda Javvadi  | Managing Director | 01-May-2013 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogish Chandra | Director | 07-Oct-2004 | Current |
| Aruna Tulasi | Director | 07-Oct-2004 | Current |
Financial Performance of Hari Hara Agri Biotech.
Hari Hara Agri Biotech Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 82.81% increase. The company also saw a substantial improvement in profitability, with a 15.97% increase in profit. The company's net worth Soared by an impressive increase of 287.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hari Hara Agri Biotech?
In 2019, Hari Hara Agri Biotech had a promoter holding of 72.73% and a public holding of 27.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chaitanya Packagings Pvt LtdActive 39 years 4 monthsYogish Chandra and Aruna Tulasi are mutual person
Donghai Packaging Machinery Private LimitedActive 15 years 2 monthsYogish Chandra and Aruna Tulasi are mutual person
- Tulasi Cotton Industries Private LimitedActive 16 years 8 months
Yogish Chandra and Aruna Tulasi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hari Hara Agri Biotech?
Unlock and access historical data on people associated with Hari Hara Agri Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hari Hara Agri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hari Hara Agri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
